AbCellera Biologics Statistics
Total Valuation
ABCL has a market cap or net worth of $1.44 billion. The enterprise value is $1.06 billion.
Important Dates
The next estimated earnings date is Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ABCL has 298.83 million shares outstanding. The number of shares has increased by 1.69% in one year.
| Current Share Class | 298.83M |
| Shares Outstanding | 298.83M |
| Shares Change (YoY) | +1.69% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 22.94% |
| Owned by Institutions (%) | 29.23% |
| Float | 202.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.69 |
| Forward PS | 39.77 |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 32.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.07, with a Debt / Equity ratio of 0.14.
| Current Ratio | 11.07 |
| Quick Ratio | 9.50 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -15.64% and return on invested capital (ROIC) is -13.22%.
| Return on Equity (ROE) | -15.64% |
| Return on Assets (ROA) | -10.95% |
| Return on Invested Capital (ROIC) | -13.22% |
| Return on Capital Employed (ROCE) | -18.48% |
| Revenue Per Employee | $55,161 |
| Profits Per Employee | -$277,961 |
| Employee Count | 596 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -33.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.00% in the last 52 weeks. The beta is 0.64, so ABCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +89.00% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 3.19 |
| Relative Strength Index (RSI) | 60.38 |
| Average Volume (20 Days) | 3,894,309 |
Short Selling Information
The latest short interest is 43.23 million, so 14.47% of the outstanding shares have been sold short.
| Short Interest | 43.23M |
| Short Previous Month | 41.78M |
| Short % of Shares Out | 14.47% |
| Short % of Float | 21.32% |
| Short Ratio (days to cover) | 8.59 |
Income Statement
In the last 12 months, ABCL had revenue of $32.88 million and -$165.67 million in losses. Loss per share was -$0.56.
| Revenue | 32.88M |
| Gross Profit | -135.88M |
| Operating Income | -246.66M |
| Pretax Income | -178.81M |
| Net Income | -165.67M |
| EBITDA | -218.38M |
| EBIT | -246.66M |
| Loss Per Share | -$0.56 |
Full Income StatementBalance Sheet
The company has $553.08 million in cash and $142.08 million in debt, giving a net cash position of $411.00 million or $1.38 per share.
| Cash & Cash Equivalents | 553.08M |
| Total Debt | 142.08M |
| Net Cash | 411.00M |
| Net Cash Per Share | $1.38 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 3.41 |
| Working Capital | 675.12M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$80.84 million and capital expenditures -$58.15 million, giving a free cash flow of -$138.99 million.
| Operating Cash Flow | -80.84M |
| Capital Expenditures | -58.15M |
| Free Cash Flow | -138.99M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -750.29% |
| Pretax Margin | -604.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.69% |
| Shareholder Yield | -1.69% |
| Earnings Yield | -11.26% |
| FCF Yield | -9.44% |
Analyst Forecast
The average price target for ABCL is $8.00, which is 65.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 65.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 48.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ABCL has an Altman Z-Score of 1.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 3 |
